From weak demand for REIT fundraising to a sharp selloff in one of Europe’s biggest companies, markets are sending mixed signals, hosted by Michelle Martin with Willie Keng, Founder, Dividend Titan. (https://www.dividendtitan.com)

Lendlease REIT’s preferential offering saw a tepid response, raising concerns about investor appetite for yield plays in a higher-rate world.

At the same time, Novo Nordisk - once a market darling - has plunged sharply, wiping out billions in value.

We unpack whether this is a valuation reset, competitive pressure, or a deeper shift in the obesity drug narrative.

What does this mean for income investors relying on REITs and growth investors chasing healthcare innovation?

Plus; Michelle and Willie discuss how if the AI craze is leading us to  overlook skills important to build to flourish.